Custom Virus-Like Particle Development

Virus-like particles (VLPs) offer distinct advantages as vaccine platforms, but their effective application relies on thoughtful design, controlled assembly, and rigorous characterization. Alfa Chemistry provides custom VLP development services to support the translation of vaccine concepts into well-defined, reproducible, and biologically relevant particle systems.

Our service offerings are designed to address both the scientific complexity of VLP engineering and the practical challenges associated with vaccine research and development.

Antigen Design and Engineering

Successful VLP-based vaccine development begins with rational antigen design. Alfa Chemistry supports this process through:

• Identification of appropriate viral structural proteins capable of stable particle assembly
• Optimization of antigen domains to improve structural stability and surface exposure
• Design of fusion or chimeric constructs to enhance immune recognition

These strategies enable precise control over antigen presentation and help ensure that target epitopes are displayed in their most biologically relevant configurations.

Expression and Assembly Optimization

Viral structural proteins differ significantly in their folding behavior and assembly requirements. Our development workflows include systematic optimization of expression and assembly parameters to promote:

• Efficient and reproducible particle formation
• Structural uniformity and particle homogeneity
• Minimization of aggregation and incomplete assembly

Careful control of these variables is essential to ensure that observed biological performance reflects intrinsic antigen properties rather than process-related artifacts.

Purification and Analytical Characterization

Purification of virus-like particles presents unique challenges due to their size, complexity, and sensitivity to processing conditions. Alfa Chemistry designs purification strategies tailored to the physicochemical properties of each VLP, followed by comprehensive analytical characterization, including:

• Evaluation of particle integrity and morphology
• Verification of protein composition and assembly state
• Assessment of residual host-derived impurities

The resulting data provide a robust foundation for informed decision-making throughout vaccine development.

Formulation Feasibility

To support downstream evaluation, Alfa Chemistry offers formulation feasibility studies focused on:

• Buffer compatibility and stability profiling
• Interaction assessment with adjuvants or excipients
• Handling, storage, and short-term stability considerations

These studies help bridge the gap between antigen design and functional vaccine candidates suitable for further investigation.

Service Advantages

• Integrated expertise spanning VLP design, production, and analytical evaluation
• Flexible service scope aligned with project objectives and development stage
• Strong emphasis on reproducibility, data quality, and scientific rigor

Our products and services are for research use only and cannot be used for any clinical purposes.

Online Inquiry

Custom Virus-Like Particle Development

Send A Message